Selective Microbial Biomarkers in Type-2 Diabetes with Principal Component Analysis and Receiver-operating Characteristic Curves

Document Type : Original Article

Authors

1 Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, Nnamdi, Azikiwe University, Nnewi Campus, Nnewi, Nigeria

2 Department of Medicine, Faculty of Medicine, College of Health Sciences, Nnamdi Azikiwe University,Nnewi Campus, Anambra State, Nigeria

3 Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria

4 Uzobiogene Genomics, London, Ontario, Canada

Abstract

Background and aim: Gut microbiota dysbiosis has been associated with metabolic disorders, such as obesity and Type-2diabetes Mellitus. This study evaluated the sensitivity, specificity, and diagnostic accuracy of selective biological markers in T2 diabetes.
Materials and methods: Stool samples were collected from 110 confirmed T2DM and ten non-T2DM subjects, and bacterial DNA extracted. The V4 areas of bacterial 16S rRNA were amplified and sequenced using an Illumina NextSeq 500 platform.
Results: There was a strong correlation between the family Streptococcaceae, Sphingobacteriaceae, Alcaligenaceae, Paraprevotellaceae, and Enterobacteriaceae with T2D. The genus-Faecalibacterium and genus-Roseburia demonstrated a negative correlation with T-2D. The Receiver-operating characteristic (ROC) of the Area Under Curve (AUC) value of gut microbiome was in increasing order with family> Genus > Species > Order> Class.Therefore, we classified the diagnostic accuracy as poor (0.6 < ROC AUC ≤ 0.7), failed (ROC AUC ≤ 0.6), good (0.8 < ROC AUC  ≤  0.9), excellent (0.9 < ROC AUC ≤ 1.0) and fair (0.7 < ROC AUC ≤ 0.8).According to the results, the selected bacterial family/taxa provided fair diagnostic tools followed by genus/taxa, whereas other bacterial genera /taxa failed the diagnostic accuracy.
Conclusion: We could demonstrate the gut microbiome-based classifiers' potential for identifying people suffering from the increased risks for T2D. The findings also revealed that genus-Faecalibacterium, genus-Roseburia, and genus-Phascolarctobacterium were the main discriminants for T2D.

Keywords

Main Subjects


[1]  Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55-60. https://doi.org/10.1038/nature11450.
[2]  Li Q, Chang Y, Zhang K, Chen H, Tao S, Zhang Z. Implication of the gut microbiome composition of type 2 diabetic patients from northern China. Scientific reports. 2020;10(1):1-8. https://doi.org/10.1038/s41598-020-62224-3.
[3] Karlsson FH, Tremaroli V, Nookaew I, Bergström G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99-103. https://doi.org/10.1038/nature12198.
[4]  Zhang P, West NP, Chen PY, Thang MW, Price G, Cripps AW, et al. Selection of microbial biomarkers with genetic algorithm and principal component analysis. BMC bioinformatics. 2019;20(6):1-8. https://doi.org/10.1186/s12859-019-3001-4.
[5]  Hair, J. F., Anderson, R. E., Tatham, R. L., & Black, W. C. Multivariate data analysis (4th Ed.). Upper Saddle River, N J: Prentice Hall. 1995.
[6]  Mardia  KV,  Kent  JM,  Bibby JM.  Multivariate analysis. London: Academic press. 521.1980.
[7]  Newby PK, Muller D, Hallfrisch J, Andres R, Tucker KL. Food patterns measured by factor analysis and anthropometric changes in adults. The American journal of clinical nutrition. 2004;80(2):504-13. https://doi.org/10.1093/ajcn/80.2.504.
[8]  Harsch IA, Konturek PC. The role of gut microbiota in obesity and type 2 and type 1 diabetes mellitus: new insights into “old” diseases. Medical sciences. 2018;6(2):32.
 [9]  Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proceedings of the national academy of sciences. 2011;108(Supplement 1):4516-22.
[10] Ringner M(2008).What is principal component analysis?Natural   
       Biotechnology. 26(3):303–304. DOI: 10.1038/nbt0308-303.
[11] Jolliffe IT, Cadima J. Principal component analysis: a review and recent developments. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences. 2016;374(2065):20150202. https://doi.org/10.1098/rsta.2015.0202.
[12] Huang T, Li J, Zhang W. Application of principal component analysis and logistic regression model in lupus nephritis patients with clinical hypothyroidism. BMC medical research methodology. 2020;20:1-7. https://doi.org/10.1186/s12874-020-00989-x.
[13] Ling Z, Liu X, Luo Y, Wu X, Yuan L, Tong X, et al. Associations between vaginal pathogenic community and bacterial vaginosis in Chinese reproductive-age women. PLoS One. 2013;8(10):e76589.
[14] Oshim IO, Agbakoba NR, Anukam KC. Gut Microbiota Compositions and Modulation of Bacterial Metabolic Functional Genes in Type-2 Diabetes Mellitus Individuals at Nnewi, Anambra State. J Med Lab Sci. 2020;30(3):136-50. http://doi.org/10.5281/zenodo.4050381.
[15] Larsen N, Vogensen FK, Van Den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS one. 2010;5(2):e9085.
[16] Hur KY, Lee MS. Gut microbiota and metabolic disorders. Diabetes & metabolism journal. 2015;39(3):198. http://dx.doi.org/10.4093/dmj.2015.39.3.198.
Volume 3, Issue 1
March 2021
Pages 23-34
  • Receive Date: 08 January 2021
  • Revise Date: 24 February 2021
  • Accept Date: 09 March 2021
  • First Publish Date: 09 March 2021